Function-blocking autoantibodies to the melanin-concentrating hormone receptor in vitiligo patients
Open Access
- 1 August 2006
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 86 (8) , 781-789
- https://doi.org/10.1038/labinvest.3700438
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Thyrotropin receptor autoantibodies in Graves' diseaseTrends in Endocrinology & Metabolism, 2005
- The Transcription Factors SOX9 and SOX10 Are Vitiligo Autoantigens in Autoimmune Polyendocrine Syndrome Type IJournal of Biological Chemistry, 2001
- Autoantibodies to tyrosinase‐related protein‐1 detected in the sera of vitiligo patients using a quantitative radiobinding assayBritish Journal of Dermatology, 1998
- Differential effect of thyroid-stimulating hormone (TSH) on intracellular free calcium and cAMP in cells transfected with the human TSH receptorJournal of Endocrinology, 1998
- In Vivo Destruction of Melanocytes by the IgG Fraction of Serum from Patients with VitiligoJournal of Investigative Dermatology, 1995
- An investigation of the ability of TSH and Graves' immunoglobulin G to increase intracellular calcium in human thyroid cells, rat FRTL-5 thyroid cells and eukaryotic cells transfected with the human TSH receptorJournal of Endocrinology, 1994
- Review of the etiopathomechanism of vitiligo: A convergence theoryExperimental Dermatology, 1993
- Relation Between the Incidence and Level of Pigment Cell Antibodies and Disease Activity in VitiligoJournal of Investigative Dermatology, 1991
- Correlation between vitiligo antibodies and extent of depigmentation in vitiligoJournal of the American Academy of Dermatology, 1986
- Antibodies to normal human melanocytes in vitiligo.The Journal of Experimental Medicine, 1983